Investor Alert

March 30, 2020, 5:03 p.m. EDT


Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

(EDGAR Online via COMTEX) -- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

You should read the following discussion and analysis together with our audited consolidated financial statements and the accompanying notes. This discussion contains forward-looking statements, including statements regarding our expected financial position, business and financing plans. These statements involve risks and uncertainties. Our actual results could differ materially from the results described in or implied by these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Report, particularly under the headings "Caution Concerning Forward-Looking Statements" and "Risk Factors."

Results of Operations

Factors Which May Influence Results of Operations

We are not aware of any material trends or uncertainties, other than national economic conditions affecting our industry generally, that may reasonably be expected to have a material impact, favorable or unfavorable, on our revenues or income other than those listed in Part I, Item 1A, Risk Factors, of this Annual Report on Form 10-K. However, due to the recent outbreak of the coronavirus in the U.S. and globally, our business and operations may be impacted. The impact of the coronavirus on our future results could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus, the success of actions taken to contain or treat the coronavirus, and reactions by consumers, companies, governmental entities and capital markets.

2019 Compared to 2018

Consolidated Revenues, Gross Margin and Backlog

Total revenues for the year ended December 31, 2019 were $31,897,000, an increase of $7,027,000, or 28.3% from revenues of $24,870,000 in 2018. The increase was primarily due to an increase in filter sales of $4,230,000.

Consolidated gross margin, which is consolidated revenues less manufacturing cost of sales, as a percentage of revenues increased to 39.2% from 38.8% for the year ended December 31, 2019, compared to the prior year. The increase reflects our strategy to move away from the low margin commodities business and focus on achieving revenue growth through the development of more complex, higher margin products, particularly in the aerospace and defense product markets.

As of December 31, 2019, our order backlog was $21,857,000, an increase of 24.9% compared to a backlog of $17,506,000 as of December 31, 2018. The significant increase in backlog is primarily due to receiving orders much earlier than expected. The backlog of unfilled orders includes amounts based on signed contracts as well as agreed letters of intent, which we have determined are firm orders likely to be fulfilled in the next 12 months.

Order backlog is adjusted quarterly to reflect project cancellations, deferrals, revised project scope and cost, and sales of subsidiaries, if any. We expect to fill our entire order backlog as of December 31, 2019 in 2020, but cannot provide assurances as to what portion of the order backlog will be fulfilled in a given year.

Operating Income

Operating income of $3,439,000 for the year ended December 31, 2019, was an improvement of $2,009,000 from the year ended December 31, 2018 operating income of $1,430,000. The improvement was primarily due to the $2,857,000 increase in gross margins as a result of increased sales, offset partially by increased operating expenses of ($848,000). Engineering, selling and administrative expenses were 28.4% of revenue for the year ended December 31, 2019, compared to 33.1% of revenue for the year ended December 31, 2018.

Interest Income, Net

Interest income, net, showed income of $2,000 for the years ended December 31, 2019 and December 31, 2018.

Other Income, Net

For the years ended December 31, 2019 and 2018, other income, net was $484,000 and $138,000, respectively, an increase of $346,000 in the current year. This increase resulted directly from the investment income from our investment portfolio.

Income Tax Provision

We must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, tax benefits and deductions and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes to these estimates may result in an increase or decrease to the tax provision in a subsequent period.

In assessing the realizability of deferred tax assets, in accordance with the provisions of Accounting Standards Codification 740, Income Taxes ("ASC 740"), we consider whether it is more likely than not that some portion or all of our deferred tax assets will or will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become realizable. Based upon the weighting of positive and negative evidence, the Company has determined the results of future operations will generate sufficient taxable income that it is more likely than not that deferred tax assets of $3,307,000 at December 31, 2019 will be utilized in the foreseeable future. At December 31, 2019, the Company's remaining valuation allowance was $388,000, consisting primarily of tax credits expiring between 2020 and 2024. Should a change in circumstances lead to a change in judgment about the ability to realize deferred tax assets in future years, the Company will adjust related valuation allowances in the period that the change in circumstances occurs, along with a corresponding increase or charge to income.

We recorded an income tax (benefit) provision for the years ended December 31, 2019 and 2018 of ($3,107,000) and $165,000, respectively. The change in our income tax (benefit) provision from the prior year was primarily due to the reversal of ($3,344,000) from the valuation allowance in the third quarter of 2019.

Net Income

Net income for the year ended December 31, 2019 was $7,016,000 compared with income of $1,405,000 for the year ended December 31, 2018. Basic net income per share for the years ended December 31, 2019 and 2018 was $1.44 and $0.30, respectively. Diluted net income per share for the years ended December 31, 2019 and 2018 was $1.41 and $0.29, respectively.

Liquidity and Capital Resources

As of December 31, 2019 and 2018, cash and cash equivalents were $12,453,000 and $15,508,000, respectively.

Cash provided by operating activities was $2,666,000 and $1,656,000 for the years ended December 31, 2019 and 2018, respectively. The $1,010,000 increase was primarily due to the improvement in net income of $5,611,000, offset by the change in deferred tax assets of ($3,226,000), changes in operating assets and liabilities of ($1,210,000), and the increased gain on marketable securities of $(234,000).

Cash used in investing activities for the years ended December 31, 2019 and 2018 was ($6,163,000) and ($324,000), respectively. In 2019, we purchased marketable securities totaling $(5,050,000), and sold marketable securities totaling $3,400,000 and invested $(3,350,000) in an unconsolidated subsidiary. The capital expenditures in 2019 related primarily to improvements to the facilities of $622,000 along with the purchase of production machinery of $330,000.

For the year ended December 31, 2019, financing activity related to proceeds from stock options exercised of $442,000. For the year ended December 31, 2018, financing activity related to the $927,000 received as a result of warrant exercises, along with $27,000 received from exercises of stock options, and payments of ($28,000) related to issuance costs for the rights offering in 2017.

As of December 31, 2019, our consolidated working capital was $24,586,000, compared to $24,633,000 as of December 31, 2018. As of December 31, 2019, we had current assets of $28,910,000, current liabilities of $4,324,000 and a ratio of current assets to current liabilities of 6.69 to 1.00. As of December 31, 2018, we had current assets of $27,385,000, current liabilities of $2,752,000 and a ratio of current assets to current liabilities of 9.95 to 1.00.

Management continues to focus on efficiently managing working capital requirements to match operating activity levels, and will seek to deploy the Company's working capital where it will generate the greatest returns.

We believe that existing cash and cash equivalents and cash generated from operations will be sufficient to meet our ongoing working capital and capital expenditure requirements for the next 12 months from the date of this filing. However, we are continuing to monitor the outbreak of the coronavirus and its impact on our customers and suppliers, as well as our industry as a whole. The magnitude and duration of the pandemic and its impact on our operations and liquidity is uncertain as of the filing date of our report as this continues to evolve globally. However, if the outbreak continues on its current trajectory, such impacts could grow and become material. To the extent that our customers and suppliers continue to be impacted by the coronavirus outbreak, or by the other risks disclosed in our report, this could materially disrupt our business operations.

Our Board has adhered to a practice of not paying cash dividends. This policy takes into account our long-term growth objectives, including our anticipated investments for organic growth, potential technology acquisitions or other strategic ventures, and stockholders' desire for capital appreciation of their holdings. No cash dividends have been paid to the Company's stockholders since January 30, 1989, and none are expected to be paid for the foreseeable future.

Critical Accounting Policies

Our significant accounting policies are described in Note A. "Accounting and Reporting Policies" in the accompanying Notes to the Consolidated Financial Statements. The Company's discussion and analysis of its financial condition and results of operations are based upon the Company's consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to the carrying value of inventories, the likelihood of collecting outstanding accounts receivable, value of stock-based compensation, and the provision for income taxes. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In the past, actual results have not been materially different from our estimates. However, results may differ from these estimates under different assumptions or conditions.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Mar 30, 2020

(c) 1995-2020 Cybernet Data Systems, Inc. All Rights Reserved

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.